Ascendis Pharma (ASND) Misses Q3 EPS by EUR0.04

November 30, 2016 4:11 PM EST
Get Alerts ASND Hot Sheet
Trade ASND Now!
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Ascendis Pharma (NASDAQ: ASND) reported Q3 EPS of (EUR0.72), EUR0.04 worse than the analyst estimate of (EUR0.68).

For earnings history and earnings-related data on Ascendis Pharma (ASND) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment